Literature DB >> 36264335

Polygenic risk score and biochemical/environmental variables predict a low-risk profile of age-related macular degeneration in Sardinia.

Rita Serra1,2,3, Andrea Angius4, Vincenzo Rallo5, Antonio Pinna6, Maristella Steri5, Maria Grazia Piras5, Michele Marongiu5, Florence Coscas7, Myriam Gorospe8, David Schlessinger8, Edoardo Fiorillo5, Francesco Cucca9.   

Abstract

PURPOSE: To ascertain the prevalence and clinical and genetic features of age-related macular degeneration (AMD) in subjects living in the Lanusei valley, Central Sardinia, Italy, involved in a study on ageing (SardiNIA project).
METHODS: A total of 814 volunteers aged ≥ 50 years, randomly selected from the SardiNIA project dataset, were included. A color fundus (CF) photograph of the 30° central retina of each eye was obtained and graded according to the Age-Related Eye Disease Study system. Life-style choices were investigated using standardized questionnaires. The concentrations of several inflammatory biomarkers (i.e., complement component, fibrinogen, and C-reactive protein) were measured. Polygenic risk score (PRS) was calculated and compared with results obtained from a European cohort.
RESULTS: A total of 756 subjects had gradable CF photographs for AMD detection. In 91.3%, no signs of AMD were observed. The prevalence rates of early and late AMDs were 6.9% and 0.6%, respectively. A total of 85% of subjects were physically active; only 13.5% were current smokers. Low concentrations of complement component, fibrinogen, and C-reactive protein were found. We calculated the polygenic risk scores (PRS) using 40 AMD markers distributed on several candidate genes in Europeans and Sardinians. The mean PRS value was significantly lower in Sardinians than in the Europeans (0.21 vs. 0.248, respectively, p = 1.18 × 10-77).
CONCLUSIONS: In our cohort, most subjects showed no sign of any AMD type and late AMD was a condition rarely observed. Results of genetic, biochemical, and life-style investigation support the hypothesis that Sardinia population may present of a peculiar background with a protective effect against AMD development.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  AREDS grading system; Age-related macular degeneration; Biochemical indices; Polygenic risk scores; Sardinia

Year:  2022        PMID: 36264335     DOI: 10.1007/s00417-022-05858-5

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.535


  24 in total

1.  Do we need a new classification for choroidal neovascularization in age-related macular degeneration?

Authors:  K Bailey Freund; Sandrine A Zweifel; Michael Engelbert
Journal:  Retina       Date:  2010-10       Impact factor: 4.256

2.  The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences.

Authors:  Johanna M Seddon; Jennifer Cote; William F Page; Steven H Aggen; Michael C Neale
Journal:  Arch Ophthalmol       Date:  2005-03

Review 3.  Age-related macular degeneration.

Authors:  Laurence S Lim; Paul Mitchell; Johanna M Seddon; Frank G Holz; Tien Y Wong
Journal:  Lancet       Date:  2012-05-05       Impact factor: 79.321

Review 4.  Dry age-related macular degeneration: mechanisms, therapeutic targets, and imaging.

Authors:  Catherine Bowes Rickman; Sina Farsiu; Cynthia A Toth; Mikael Klingeborn
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-12-13       Impact factor: 4.799

5.  The prevalence of age-related macular degeneration in Italy (PAMDI) study: report 1.

Authors:  Stefano Piermarocchi; Tatiana Segato; Pasquale Scopa; Morena Masetto; Stela Ceca; Fabiano Cavarzeran; Tunde Peto
Journal:  Ophthalmic Epidemiol       Date:  2011-06       Impact factor: 1.648

6.  Global data on visual impairment in the year 2002.

Authors:  Serge Resnikoff; Donatella Pascolini; Daniel Etya'ale; Ivo Kocur; Ramachandra Pararajasegaram; Gopal P Pokharel; Silvio P Mariotti
Journal:  Bull World Health Organ       Date:  2004-12-14       Impact factor: 9.408

Review 7.  Current concepts in the pathogenesis of age-related macular degeneration.

Authors:  Marco A Zarbin
Journal:  Arch Ophthalmol       Date:  2004-04

8.  The prevalence of age-related maculopathy in the Rotterdam Study.

Authors:  J R Vingerling; I Dielemans; A Hofman; D E Grobbee; M Hijmering; C F Kramer; P T de Jong
Journal:  Ophthalmology       Date:  1995-02       Impact factor: 12.079

Review 9.  Age-related macular degeneration and the aging eye.

Authors:  Rita Ehrlich; Alon Harris; Nisha S Kheradiya; Diana M Winston; Thomas A Ciulla; Barbara Wirostko
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

10.  Genome-wide association meta-analysis for early age-related macular degeneration highlights novel loci and insights for advanced disease.

Authors:  Thomas W Winkler; Felix Grassmann; Caroline Brandl; Christina Kiel; Felix Günther; Tobias Strunz; Lorraine Weidner; Martina E Zimmermann; Christina A Korb; Alicia Poplawski; Alexander K Schuster; Martina Müller-Nurasyid; Annette Peters; Franziska G Rauscher; Tobias Elze; Katrin Horn; Markus Scholz; Marisa Cañadas-Garre; Amy Jayne McKnight; Nicola Quinn; Ruth E Hogg; Helmut Küchenhoff; Iris M Heid; Klaus J Stark; Bernhard H F Weber
Journal:  BMC Med Genomics       Date:  2020-08-26       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.